PROFOUND MEDICAL CORP. Increase (Decrease) in Inventories
PROFOUND MEDICAL CORP. (PROF) reported Increase (Decrease) in Inventories of $2.69 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-06
- PROFOUND MEDICAL CORP. increase (decrease) in inventories for the quarter ending 2026-06-30 was $1.69M, a 2.82% decline year-over-year.
- PROFOUND MEDICAL CORP. increase (decrease) in inventories for the quarter ending 2026-03-31 was $996.00K, a 1.22% increase year-over-year.
- PROFOUND MEDICAL CORP. increase (decrease) in inventories for the quarter ending 2025-12-31 was $229.00K.
- PROFOUND MEDICAL CORP. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$130.00K.
- PROFOUND MEDICAL CORP. increase (decrease) in inventories for fiscal 2025 was $2.82M.
- PROFOUND MEDICAL CORP. increase (decrease) in inventories for fiscal 2024 was -$656.00K.
- PROFOUND MEDICAL CORP. increase (decrease) in inventories for fiscal 2023 was -$353.00K.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.69M 10-Q · filed 2026-08-06 | $2.92M derived: sum of 3 quarters · filed 2026-08-06 | $2.79M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $996.00K 10-Q · filed 2026-05-07 | $1.23M derived: sum of 2 quarters · filed 2026-05-07 | $1.09M derived: sum of 3 quarters · filed 2026-05-07 | $2.83M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $229.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $99.00K derived: sum of 2 quarters · filed 2026-03-05 | $1.84M derived: sum of 3 quarters · filed 2026-08-06 | $2.82M 10-K · filed 2026-03-05 |
| 2025-09-30 | -$130.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.61M derived: sum of 2 quarters · filed 2026-08-06 | $2.59M 10-Q · filed 2025-11-13 | $2.11M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.72M 10-Q · filed 2026-08-06 | $2.24M derived: sum of 3 quarters · filed 2026-08-06 | $1.90M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $984.00K 10-Q · filed 2026-05-07 | $504.00K derived: sum of 2 quarters · filed 2026-05-07 | $160.00K derived: sum of 3 quarters · filed 2026-05-07 | $148.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$480.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$824.00K derived: sum of 2 quarters · filed 2026-03-05 | -$836.00K derived: sum of 3 quarters · filed 2026-03-05 | -$656.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | -$344.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$356.00K derived: sum of 2 quarters · filed 2025-11-13 | -$176.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | -$12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $168.00K 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $180.00K 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$353.00K 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |